Target Gene Table
VIS IDVirusEnsembl IDGene TypeTarget GeneOncogeneTumor Suppressor GeneNCBI IDUniprot ID
TVIS20051435HPVENSG00000102755.13protein_codingFLT1YesNo2321L7RSL3
P17948
TVIS20051277HPVENSG00000102755.13protein_codingFLT1YesNo2321L7RSL3
P17948
TVIS20035648HPVENSG00000102755.13protein_codingFLT1YesNo2321L7RSL3
P17948
TVIS20014193HPVENSG00000102755.13protein_codingFLT1YesNo2321L7RSL3
P17948
TVIS20051335HPVENSG00000102755.13protein_codingFLT1YesNo2321L7RSL3
P17948
TVIS44023476HTLV-1ENSG00000102755.13protein_codingFLT1YesNo2321L7RSL3
P17948
TVIS44020669HTLV-1ENSG00000102755.13protein_codingFLT1YesNo2321L7RSL3
P17948
TVIS44023477HTLV-1ENSG00000102755.13protein_codingFLT1YesNo2321L7RSL3
P17948
TVIS44014539HTLV-1ENSG00000102755.13protein_codingFLT1YesNo2321L7RSL3
P17948
TVIS44041242HTLV-1ENSG00000102755.13protein_codingFLT1YesNo2321L7RSL3
P17948
TCGA Plot Options
Drug Information
GeneFLT1
DrugBank IDDB11800
Drug NameTivozanib
Target IDBE0000029
UniProt IDP17948
Regulation Typeinhibitor
PubMed IDs32234426; 32547647
CitationsWang J, Bruin MAC, Gan C, Lebre MC, Rosing H, Beijnen JH, Schinkel AH: Brain accumulation of tivozanib is restricted by ABCB1 (P-glycoprotein) and ABCG2 (breast cancer resistance protein) in mice. Int J Pharm. 2020 May 15;581:119277. doi: 10.1016/j.ijpharm.2020.119277. Epub 2020 Mar 28.@@Salgia NJ, Zengin ZB, Pal SK: Tivozanib in renal cell carcinoma: a new approach to previously treated disease. Ther Adv Med Oncol. 2020 May 22;12:1758835920923818. doi: 10.1177/1758835920923818. eCollection 2020.
GroupsApproved; Investigational
Direct ClassificationDiarylethers
SMILESCOC1=C(OC)C=C2C(OC3=CC(Cl)=C(NC(=O)NC4=NOC(C)=C4)C=C3)=CC=NC2=C1
Pathways
PharmGKB
ChEMBLCHEMBL1289494